France – Produits pharmaceutiques – Fourniture de produits radiopharmaceutiques pour le GCS Médecine nucléaire de Beauvais.
AI summary
This tender concerns the supply and delivery of radiopharmaceutical products for the GCS Nuclear Medicine department in Beauvais, France. The contract is structured as a framework agreement to ensure ongoing provision of nuclear medicine imaging and therapeutic agents.
Pharmaceutical distributors or manufacturers specializing in radiopharmaceuticals with proper licensing and regulatory compliance for nuclear medicine supplies should bid.
Suppliers must be authorized to distribute radiopharmaceutical products and comply with French and European pharmaceutical regulations. Ability to ensure reliable delivery schedules and maintain product traceability is essential.
Frequently asked questions
What is this tender about?
This tender concerns the supply and delivery of radiopharmaceutical products for the GCS Nuclear Medicine department in Beauvais, France. The contract is structured as a framework agreement to ensure ongoing provision of nuclear medicine imaging and therapeutic agents.
What are the requirements for suppliers?
Suppliers must be authorized to distribute radiopharmaceutical products and comply with French and European pharmaceutical regulations. Ability to ensure reliable delivery schedules and maintain product traceability is essential.
What type of company should bid?
Pharmaceutical distributors or manufacturers specializing in radiopharmaceuticals with proper licensing and regulatory compliance for nuclear medicine supplies should bid.
Who is the buyer?
The buyer is GCS MEDECINE NUCLEAIRE DE BEAUVAIS.
When does this tender close?
Submissions close on September 25, 2026.
What is the estimated value?
The estimated value is 0 EUR.
Le présent accord-cadre a pour objet la fourniture et livraison de produits radiopharmaceutiques pour le GCS de médecine nucléaire de Beauvais.
FDG (Fluorodesoxyglucose)
F-Choline (Fluorocholine)
F-DOPA (Fluorodopa)
F-PSMA (PSMA Fluoré)
FNa (Fluorure de sodium)
Traceurs plaques amyloïdes
Fluciclovine
- PriceVoir article 8.2 du Règlement de Consultation50%
- QualityValeur Technique : Voir article 8.2 du Règlement de consultation0%
- QualityDéveloppement durable : Voir article 8.2 du Règlement de consultation10%
- PriceVoir article 8.2 du règlement de consultation50%
- QualityValeur technique : Voir article 8.2 du règlement de consultation40%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation10%
- QualityValeur technique du produit: Voir article 8.2 du règlement de consultation6%
- QualityDéveloppement durable : Voir article 8.2 du règlement de consultation5%
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…